Needle-free drug delivery

The injection, without the needlefor diabetesfor osteoporosisfor obesityfor autoimmune diseasesfor growth disordersfor chronic injections
Sonora is a small wearable that uses ultrasound to deliver, through intact skin, the drugs patients inject today.
Investigational device · first-in-human study completed in 2026

injections a year. Every one of them, a needle.
Nobody likes needles, so people stop taking treatments that work. We founded Medicsen in 2015 after a young girl with diabetes refused to keep injecting insulin.

The answer
Worn on the skin.Not injected.
- Nothing pierces the skinNo needle and no cannula. Ultrasound carries the drug across.
- You wear itOn the arm or the abdomen, at home, under your clothes.
- You keep itOne reusable device. Only the drug cartridge changes.
How it works · ultrasound
Open.
Ultrasound makes the outer layer of the skin briefly permeable.
Deliver.
The drug crosses the skin. No needle, no cannula.
Close.
When the ultrasound stops, the skin barrier recovers.

Three parts
A device you keep. A cartridge you change.
A reusable body, a rechargeable pulse unit and one cartridge per drug.
It clicks together
Load the dose. Nothing sharp to handle.
The drug comes in the cartridge. No syringe to fill and no needle to throw away.
You wear it
Stick it on. Get on with your day.
5 × 3 × 1.4 cm on the arm or the abdomen, with a battery designed for 72 hours.
The dose crosses
The dose goes in. The needle never does.
Ultrasound opens the way, the drug crosses, and the skin closes again.
The invention
The hard part: an ultrasound generator small enough to wear.
Patent EP3909508B1 granted in the EU, US, China, Japan and Israel, plus trade secret on the emission parameters.
Size and battery life are design targets. Sonora is an investigational device.
The platform
One device. Many medicines.
Only the cartridge changes. The same device is designed for small peptides and for large antibodies.

Insulin
Tested in animalsDiabetesTeriparatide
Tested in humansOsteoporosisGLP‑1
Tested in the labDiabetes and obesityAntibodies
Tested in the labLarge biologic drugs
Does it work?
Proven in animals. Safe in humans.
Three studies in animals and one in people. In every one, without ultrasound no drug crossed the skin.
Insulin, in animals
First proof that the drug reaches the blood through intact skin.
12pigsTeriparatide, under GLP
Comparable drug levels, adjusted to delivered volume, and the same time to peak as the injection pen: 39 vs 37 minutes.
15pigsFirst in humans
All six volunteers completed the study. No serious events, no pain or itching reported.
6/6volunteersThe refined device
Reproducible absorption with the configuration that goes into the next human study.
18pigsNext: drug levels in humans
Head to head with the injection pen. Results expected.
24volunteers

















Who backs us
Ten years, more than 50 awards.
Advance QueenslandHotDesq · Round 2 · 2017
AmgenM2D2 $200K Challenge · 2023
Comunidad de MadridPremio Emprendedores madri+d · 2020
CPHI Pharma AwardsMost innovative drug delivery device · 2023
EIT HealthBridgehead programme · 2019
GE HealthcareHealth Venture Lab winner · 2019
Global Entrepreneurship NetworkGlobal Entrepreneurship Network · 2023
Healthcare Innovation World Cup1st place · Healthcare Innovation World Cup · 2019
InnolabsBarcelona · 2nd prize · 2017
K-Startup Grand ChallengeK-Startup Grand Challenge · 2020
Lilly & UnLtdEmprende inHealth · 2016
Fundación MAPFRESocial Innovation Awards · winner · 2021
Medi'nov ConnectionMedi'nov Connection · 2025
MIT Technology ReviewSpanish innovation of the year · 2017
Quality Innovation AwardsQuality innovation awards 2021
SanitasSanitas Disruptive · finalist · 2018
South SummitMost Innovative Winner · 2020
UPMactúaupm · 2nd prize · 20161 / 18The team
Engineers, clinicians and dealmakers.
18people. Three co‑founders still leading since 2015, with every discipline in-house: ultrasound, electronics, biology, clinical, quality and regulatory.


















AdvisorsPatricia CremadesCo‑founder and medical advisor+ 5 advisors
Contact
Fewer needles,
less waste, less pain.
Patients, doctors, pharma companies, hospitals, researchers and people who want to build it with us.







